Breaking Oncology / Hematology | Physician's Weekly
Advertisement

Breaking Oncology / Hematology

FDA Approves Amivantamab for NSCLC with EGFR Mutations

The first targeted treatment for this population requires Dx with an FDA-approved test The FDA granted intravenous amivantamab-vmjw (Rybrevant) accelerated approval for adult patients with non-small cell lung cancer with...

FDA OKs Pegcetacoplan for Paroxysmal Nocturnal Hemoglobinuria

Patients with rare blood disease can access drug through REMS The FDA approved subcutaneous pegcetacoplan (Empaveli) for adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare and serious blood disease that affects 1-1.5...

FDA OKs Nivolumab as First-line Tx for Gastric Cancers

First immunotherapy approved as first-line Tx for gastric, gastroesophageal, and esophageal cancer The FDA approved nivolumab (OPDIVO) in combination with chemotherapy as a first-line treatment for advanced or metastatic gastric...

FDA Approves AI Device to Help ID Colon Cancer

Device highlights potential lesions during colonoscopy The FDA approved an artificial intelligence (AI) device to help clinicians identify potential signs of colon cancer during a colonoscopy.The GI Genius uses an AI algorithm...

Loading

Advertisement

For latest news and updates
Email-id is invalid